S'abonner

Blood Pressure Outcomes in NICU-Admitted Infants with Neonatal Hypertension: A Pediatric Nephrology Research Consortium Study - 11/12/23

Doi : 10.1016/j.jpeds.2023.113765 
Nianzhou Xiao, MD, MS 1, , Michelle Starr, MD, MPH 2, 3, Adrienne Stolfi, PhD 4, Gilad Hamdani, MD 5, Shireen Hashmat, MD 6, Stefan G. Kiessling, MD 7, Christina Sethna, MD 8, Mahmoud Kallash, MD 9, Robyn Matloff, MD 10, Robert Woroniecki, MD 11, Keia Sanderson, MD 12, Ikuyo Yamaguchi, MD, PhD 13, Stephen D. Cha, MD 14, Michael G. Semanik, MD 15, Rahul Chanchlani, MD 16, Joseph T. Flynn, MD, MS 3, Mark Mitsnefes, MD, MS 17
1 Department of Nephrology, Valley Children's Healthcare, Madera, CA 
2 Riley Hospital for Children and Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 
3 Division of Nephrology, Department of Pediatrics, University of Washington and Seattle Children's Hospital, Seattle, WA 
4 Department of Pediatrics, Wright State University, Dayton, OH 
5 Nephrology and Hypertension Institute, Schneider's Children Medical Center, Petah Tikva, Israel 
6 Department of Pediatrics, University of Chicago, Chicago, IL 
7 Division of Pediatric Nephrology, Kentucky Children's Hospital, University of Kentucky, Lexington, KY 
8 Division of Pediatric Nephrology, Cohen Children's Medical Center, Zucker School of Medicine at Hofstra/Northwell, Queens, NY 
9 Division of Nephrology, Nationwide Children's Hospital, Columbus, OH 
10 Division of Pediatric Nephrology, Connecticut Children's Hospital, University of Connecticut School of Medicine, Hartford, CT 
11 Division of Pediatric Nephrology and Hypertension, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY 
12 Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, NC 
13 Division of Nephrology and Hypertension, Department of Pediatrics, Oklahoma Children's Hospital at University of Oklahoma Health Sciences Center, Oklahoma, OK 
14 Division of Nephrology, Akron Children's Hospital, Akron, OH 
15 Division of Nephrology, Department of Pediatrics, University of Wisconsin at Madison, Madison, WI 
16 Division of Pediatric Nephrology, Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada 
17 Division of Nephrology and Hypertension, Cincinnati Children's Medical Center, Cincinnati, OH 

Reprint requests: Nianzhou Xiao, MD, MS, Department of Pediatric Nephrology, Valley Children's Healthcare, 9300 Valley Children's Place, Madera, CA 93636.Department of Pediatric NephrologyValley Children's Healthcare9300 Valley Children's PlaceMaderaCA93636

Abstract

Objective

To describe the blood pressure outcomes of infants admitted to the neonatal intensive care unit (NICU) with idiopathic (nonsecondary) hypertension (HTN) who were discharged on antihypertensive therapy.

Study design

Retrospective, multicenter study of 14 centers within the Pediatric Nephrology Research Consortium. We included all infants with a diagnosis of idiopathic HTN discharged from the NICU on antihypertensive treatment. The primary outcome was time to discontinuation of antihypertensive therapy, grouped into (≤6 months, >6 months to 1 year, and >1 year). Comparisons between groups were made with χ2 tests, Fisher's exact tests, and ANOVA.

Results

Data from 118 infants (66% male) were included. Calcium channel blockers were the most prescribed class of antihypertensives (56%) in the cohort. The percentages remaining on antihypertensives after NICU discharge were 60% at 6 months, 26% at 1 year, and 7% at 2 years. Antenatal steroid treatment was associated with decreased likelihood of antihypertensive therapy >1 year after discharge.

Conclusions

This multicenter study reports that most infants admitted to the NICU diagnosed with idiopathic HTN will discontinue antihypertensive treatment by 2 years after NICU discharge. These data provide important insights into the outcome of neonatal HTN, but should be confirmed prospectively.

Le texte complet de cet article est disponible en PDF.

Keywords : hypertension, pediatric, neonates, NICU

Abbreviations : ACE, HTN, NICU


Plan


 N.X. and M.S. contributed equally.
 Portions of this data were presented as a platform presentation at Pediatric Academic Society Meeting, April 24-May 19, 2019, Baltimore, MD.
 Deidentified individual participant data will be made available to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal.


© 2023  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 264

Article 113765- janvier 2024 Retour au numéro
Article précédent Article précédent
  • Health-Related Quality of Life for Parents of Infants with Bronchopulmonary Dysplasia
  • Kathryn E.K. Berlin, William Scott, Sara Dawson, David Brousseau, Joanne M. Lagatta
| Article suivant Article suivant
  • A Systematic Approach to Evaluate Sudden Unexplained Death in Children
  • Annelotte Maretta Pries, Jopje Marlies Ruskamp, Esther Edelenbos, Joris Fuijkschot, Ben Semmekrot, Krijn Teunis Verbruggen, Elise van de Putte, Patrycja Jolanta Puiman

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.